Extracted from this filing and checked against the source text.
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.95
Amneal Pharmaceuticals, Inc. amended credit facility of $1,960,076,527.50 with JPMorgan Chase Bank, N.A. at 2.00% (for base rate) and 3.00% (for SOFR) maturing August 1, 2032.
- Instrument
- credit facility
- Principal
- $1,960,076,527.50
- Counterparty
- JPMorgan Chase Bank, N.A.
- Rate
- 2.00% (for base rate) and 3.00% (for SOFR)
- Maturity
- August 1, 2032
- Event
- amendment
Exact text from the filing
on a cashless basis, its term loans outstanding immediately prior to the Repricing Amendment (the “Existing Term Loans) into new term loans with an aggregate principal amount of $1,960,076,527.50 (collectively, the “Converted Amendment No. 2 Term Loans”) and (y) the Company incurred a new term loan with an aggregate principal amount of $134,673,472.50 (the “Additional
View on SEC.gov
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.95
Amneal Pharmaceuticals, Inc. incurred term loan of $134,673,472.50 with JPMorgan Chase Bank, N.A. maturing August 1, 2032.
- Instrument
- term loan
- Principal
- $134,673,472.50
- Counterparty
- JPMorgan Chase Bank, N.A.
- Maturity
- August 1, 2032
- Event
- incurrence
Exact text from the filing
the Company incurred a new term loan with an aggregate principal amount of $134,673,472.50 (the "Additional Amendment No. 2 Term Loan")
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Amneal Pharmaceuticals, Inc. amended Amendment No. 2 to Term Loan Credit Agreement with JPMorgan Chase Bank, N.A., as administrative agent, and the other lenders party thereto (effective 2026-02-02).
- Action
- amendment
- Agreement
- credit facility
- Counterparty
- JPMorgan Chase Bank, N.A., as administrative agent, and the other lenders party thereto
- Effective
- 2026-02-02
Exact text from the filing
On February 2, 2026, Amneal Pharmaceuticals, Inc.’s (the "Corporation") subsidiary, Amneal Pharmaceuticals LLC (the “Company” or, the “Borrower”), and certain of the Company’s subsidiaries, as guarantors, entered into that certain Amendment No. 2 to Term Loan Credit Agreement (the “Repricing Amendment”) with JPMorgan Chase Bank, N.A., as administrative agent (the “Agent”), and the other lenders party thereto consenting to the Repricing Amendment.
View on SEC.gov